(±)-Bay K8644
SIGMA/B112 - calcium channel agonist
Synonym: 1,4-
CAS Number: 71145-03-4
Empirical Formula (Hill Notation): C16H15F3N2O4
Molecular Weight: 356.30
MDL Number: MFCD00036697
Linear Formula: C16H15F3N2O4
Product Type: Chemical
| assay | ≥97.5% (HPLC) |
| color | yellow to dark yellow |
| form | powder |
| InChI | 1S/C16H15F3N2O4/c1-8-12(1 |
| InChI key | ZFLWDHHVRRZMEI-UHFFFAOYSA |
| mp | 168-170 °C |
| Quality Level | 100 ![]() |
| SMILES string | CC1=C(C(OC)=O)C(C2=CC=CC= |
| solubility | DMSO: 20 mg/mL |
| H2O: insoluble | |
| methanol and ethanol: 63 mg/mL | |
| storage temp. | 2-8°C |
| Application: | (±)-Bay K8644 has been used as an agonist for voltage sensitive calcium channels (VSCCs) in interneurons, L-type calcium channel (LTCC) in human embryonic kidney 293 cells and viscerofugal neurons. |
| Biochem/physiol Actions: | (±)-Bay K8644 is a 1,4-dihydropyridine (DHP) derivative and an agonist for L-type Ca2+ channels. However, it′s enantiomers (-)-BAY k8644 and (+)-BAY k8644 have opposing functionality with respect to Ca2+ channels as high-potency agonist and low-potency antagonist, respectively. (±)-Bay K8644 increases influx of Ca2+ specifically at voltage-gated calcium channels. It constricts blood vessels and heart contraction. |
| Biochem/physiol Actions: | Increases influx of Ca2+ specifically at voltage-gated calcium channels. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥97.5% (HPLC) |
| mp | 168-170 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |


